Eurobio Scientific SA
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monito… Read more
Eurobio Scientific SA (ALERS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.030x
Based on the latest financial reports, Eurobio Scientific SA (ALERS) has a cash flow conversion efficiency ratio of 0.030x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€5.36 Million) by net assets (€180.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Eurobio Scientific SA - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Eurobio Scientific SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Eurobio Scientific SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurobio Scientific SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brookmount Explorations Inc
PINK:BMXI
|
-0.001x |
|
Legend Mining Ltd
AU:LEG
|
-0.014x |
|
TEAM PLC
F:1WQ
|
N/A |
|
Reino Capital SA
WAR:RNC
|
0.064x |
|
Excite Technology Services Ltd
AU:EXT
|
4.205x |
|
Generative AI Solutions Corp.
OTCMKTS:AICOF
|
-0.097x |
|
Multibax Public Company Limited
BK:MBAX
|
0.159x |
|
SFD SA ZY -10
F:7PQ
|
N/A |
Annual Cash Flow Conversion Efficiency for Eurobio Scientific SA (2007–2024)
The table below shows the annual cash flow conversion efficiency of Eurobio Scientific SA from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €178.85 Million | €16.70 Million | 0.093x | -38.88% |
| 2023-12-31 | €175.17 Million | €26.77 Million | 0.153x | -38.74% |
| 2022-12-31 | €172.67 Million | €43.07 Million | 0.249x | -39.36% |
| 2021-12-31 | €160.22 Million | €65.92 Million | 0.411x | -19.23% |
| 2020-12-31 | €107.84 Million | €54.93 Million | 0.509x | +273.22% |
| 2019-12-31 | €36.56 Million | €4.99 Million | 0.136x | +872.96% |
| 2018-12-31 | €29.62 Million | €-523.00K | -0.018x | -122.61% |
| 2017-12-31 | €31.69 Million | €2.48 Million | 0.078x | +128.78% |
| 2016-12-31 | €12.23 Million | €-3.32 Million | -0.271x | -158.84% |
| 2015-12-31 | €23.31 Million | €-2.44 Million | -0.105x | +13.43% |
| 2014-12-31 | €27.95 Million | €-3.38 Million | -0.121x | +49.18% |
| 2013-12-31 | €20.56 Million | €-4.90 Million | -0.238x | -31.31% |
| 2012-12-31 | €24.50 Million | €-4.45 Million | -0.182x | +59.12% |
| 2011-12-31 | €13.57 Million | €-6.02 Million | -0.444x | -46.82% |
| 2010-12-31 | €19.19 Million | €-5.80 Million | -0.302x | -14.79% |
| 2009-12-31 | €25.46 Million | €-6.71 Million | -0.263x | +73.33% |
| 2008-12-31 | €9.74 Million | €-9.62 Million | -0.988x | -261.60% |
| 2007-12-31 | €18.07 Million | €-4.93 Million | -0.273x | -- |